View Older Stories View More Recent Stories

Apr 17, 2023 08:05AM Abbott (ABT) FreeStyle Libre Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries
Apr 17, 2023 08:00AM Abbott's FreeStyle Libre® Continuous Glucose Monitoring Systems Obtain Significantly Expanded Coverage for Medicare Beneficiaries
Apr 14, 2023 09:01AM Abbott (ABT) Announces FDA Clearance of Reader for FreeStyle Libre 3 System
Apr 14, 2023 09:00AM FDA Clears Reader for Abbott's FreeStyle Libre® 3 System
Mar 29, 2023 09:00AM Abbott Hosts Conference Call for First-Quarter Earnings
Mar 23, 2023 09:00AM Don't Mess with Your 'Melon': Abbott and the Brain Injury Association of America Urge 'If You Hit Your Head, Get it Checked' in New Public Service Announcement
Mar 7, 2023 09:03AM Abbott (ABT) Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion
Mar 7, 2023 09:00AM Abbott Receives FDA Clearance for First Commercially Available Lab-based Blood Test to Help Evaluate Concussion
Mar 6, 2023 07:06AM Abbott (ABT) Announces FDA Clearance of FreeStyle Libre 2 and FreeStyle Libre 3 Sensors
Mar 6, 2023 07:05AM Krystal Biotech (KRYS) Appoints Catherine Mazzacco to its Board
Mar 6, 2023 07:00AM U.S. FDA Clears Abbott's FreeStyle Libre® 2 and FreeStyle Libre® 3 Sensors for Integration with Automated Insulin Delivery Systems
Mar 5, 2023 09:07AM Late-Breaking Data from Landmark COAPT™ Trial Show Long-Term Benefits of Abbott's MitraClip™ Device
Mar 4, 2023 10:41AM New Data Show Superiority of Abbott's TriClip™ Device Compared to Medical Therapy for Tricuspid Regurgitation
Feb 28, 2023 09:03AM Abbott (ABT) Says Late-Breaking Data Reinforce Benefits of Minimally Invasive Heart Devices
Feb 28, 2023 09:00AM Late-Breaking Data Reinforce Benefits of Abbott's Minimally Invasive Heart Devices
Feb 17, 2023 12:26PM Abbott Declares 397th Consecutive Quarterly Dividend
Feb 9, 2023 06:22AM Abbott (ABT) to acquire Cardiovascular Systems (CSII) for $20/share
Feb 8, 2023 06:12PM Cardiovascular Systems, Inc. Reports Fiscal 2023 Second Quarter Financial Results
Feb 8, 2023 06:05PM Abbott to Acquire Cardiovascular Systems, Inc.
Jan 26, 2023 09:02AM Abbott (ABT) Announces FDA Approves Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Jan 26, 2023 09:00AM FDA Approves Abbott's Spinal Cord Stimulation for People Living with Painful Diabetic Peripheral Neuropathy
Jan 25, 2023 07:30AM Abbott Reports Fourth-Quarter and Full-Year 2022 Results; Issues 2023 Financial Outlook
Jan 17, 2023 09:01AM Abbott (ABT) Wins FDA Approval for Navitor
Jan 17, 2023 09:00AM Abbott Receives FDA Approval for Navitor™, a Next-Generation TAVI System Designed to Treat Aortic Stenosis
Jan 6, 2023 09:00PM Abbott, Blood Centers of America Launch First-of-its-Kind Mixed Reality Experience for Use During Blood Donation
Jan 4, 2023 09:00AM Abbott Hosts Conference Call for Fourth-Quarter Earnings
Dec 21, 2022 09:00AM Abbott's FreeStyle Libre® 3 Integrated with Automated Insulin Delivery System mylife™ Loop in Germany
Dec 20, 2022 09:00AM Abbott to Present at J.P. Morgan Healthcare Conference
Dec 19, 2022 09:00AM Abbott Launches the World's Smallest Implantable, Rechargeable Spinal Cord Stimulation System for Chronic Pain
Dec 13, 2022 08:30AM Abbott and the Brain Injury Association of America launch Concussion Awareness Now coalition; team up with Rebel Wilson to raise awareness on seriousness of concussions
Dec 9, 2022 10:48AM Abbott Increases Quarterly Dividend, Marking 51 Consecutive Years of Dividend Growth
Nov 17, 2022 09:00AM Abbott Receives Three CES 2023 Innovation Awards for Advancements in Health Technology
Oct 28, 2022 09:00AM Abbott's FreeStyle Libre® is Named Best Medical Technology in Last 50 Years by the Galien Foundation
Oct 19, 2022 07:30AM Abbott Reports Third-Quarter 2022 Results and Raises Full-Year EPS Guidance
Oct 12, 2022 09:42AM Abbott and The Home Edit Redesign the Medicine Cabinet to Help People Prepare for the Upcoming Virus Season
Oct 6, 2022 09:00AM New Study Published in The New England Journal of Medicine Demonstrates Abbott's FreeStyle Libre® 2 System Has Positive Impacts on Glucose Levels and Quality of Life
Sep 28, 2022 09:00AM Abbott Hosts Conference Call for Third-Quarter Earnings
Sep 17, 2022 02:45PM Late-Breaking Data Show Breadth of Abbott's Minimally Invasive Structural Heart Technologies
Sep 15, 2022 12:56PM Abbott Declares 395th Consecutive Quarterly Dividend
Sep 8, 2022 09:00AM Three-Year Data on World's Smallest Heart Device Show Benefits of Fixing Holes in Newborn Hearts Without Surgery
Aug 29, 2022 09:00AM New Data Show Abbott's HeartMate 3™ Heart Pump Extends Life Beyond Five Years for Advanced Heart Failure Patients
Aug 23, 2022 09:03AM Abbott (ABT) Announces FDA Approval for New Proclaim Plus Spinal Cord Stimulation
Aug 23, 2022 09:00AM FDA Approves Abbott's New Spinal Cord Stimulation Device; Provides Tailored Relief to Multiple Pain Areas and Adds More Treatment Options for Evolving Pain Conditions
Aug 11, 2022 09:00AM New Study Shows Abbott's Blood Test for Concussion Could Predict Outcomes from Brain Injury and Inform Treatment Interventions
Aug 4, 2022 04:10PM Abbott and WeightWatchers Partner to Support People Living with Diabetes in Attaining their Health Goals
Jul 20, 2022 07:30AM Abbott Reports Second-Quarter 2022 Results and Raises Full-Year EPS Guidance
Jul 12, 2022 09:02AM Abbott (ABT) Granted FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression
Jul 12, 2022 09:00AM Abbott Receives FDA's Breakthrough Device Designation to Explore Use of Deep Brain Stimulation to Manage Severe Depression
Jun 29, 2022 09:00AM Abbott Hosts Conference Call for Second-Quarter Earnings
Jun 10, 2022 11:26AM Abbott Declares 394th Consecutive Quarterly Dividend
View More Recent Stories View Older Stories